No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
IGMS240517C10000
- 0.80
- +0.30+60.00%
15min DelayClose May 9 16:00 ET
0.80High0.45Low
0.45Open0.50Pre Close20 Volume125 Open Interest10.00Strike Price1.28KTurnover153.89%IV8.45%PremiumMay 17, 2024Expiry Date0.12Intrinsic Value100Multiplier7DDays to Expiry0.68Time Value100Contract SizeAmericanOptions Type0.5679Delta0.1713Gamma10.38Leverage Ratio-0.0595Theta0.0010Rho5.89Eff Leverage0.0059Vega
Intraday
- 5D
- 1D
News
Express News | Wedbush Reiterates Outperform on IGM Biosciences, Maintains $20 Price Target
IGM Biosciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 119.3% Wedbush → $20 Reiterates Outperform → Outperform 04/18/2024 31.58% HC Wainwright & Co. →
Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), IGM Biosciences (IGMS) and Elanco Animal Health (ELAN)
Express News | IGM Biosciences Inc : RBC Cuts Target Price to $20 From $21
IGM Biosciences Q1 EPS $(0.83), Inline, Sales $497.00K Miss $760.00K Estimate
IGM Biosciences (NASDAQ:IGMS) reported quarterly losses of $(0.83) per share which met the analyst consensus estimate. This is a 37.59 percent increase over losses of $(1.33) per share from the same p
IGM Biosciences, Inc. (IGMS) Reports Q1 Loss, Misses Revenue Estimates
Comments
Insiders expressed positive sentiment towards the company by buying at prices higher than current rates, reflecting their belief in the stock. The report suggests more insider buying would encourage the company.
2
Based on comprehensive media reports, I compiled a list of some institutions with deposits in the bank for your reference. $SVB Financial(SIVB.US$
ROKU: 26% cash, $487 million in Silicon Valley Bank. $Roku Inc(ROKU.US$
BLOCKFI: According to a bankruptcy filing, BlockFi has $227 million in "unprotected" funds at Silicon Valley Bank, possibly in violation of U.S. bankruptcy law.
RBLX: Roblox says 5% of its $3 billion cash and securities balance is held by S...
ROKU: 26% cash, $487 million in Silicon Valley Bank. $Roku Inc(ROKU.US$
BLOCKFI: According to a bankruptcy filing, BlockFi has $227 million in "unprotected" funds at Silicon Valley Bank, possibly in violation of U.S. bankruptcy law.
RBLX: Roblox says 5% of its $3 billion cash and securities balance is held by S...
4
2
$IGM Biosciences(IGMS.US$ C'mon.. Just rise a little bit more...... =/
Gainers
• $MillerKnoll(MLKN.US$ +12.4%, $BioNTech(BNTX.US$ +7.4%, $Lululemon Athletica(LULU.US$ +6.5% (also authorizes $1 bln stock repurchase program)
• $Adagio Therapeutics(ADGI.US$ +52.47% (announces ADG20 (adintrevimab) is the first monoclonal antibody to meet primary endpoints with statistical significance across pre- and post-exposure prophylaxis and treatment for COVID-19 and plans to seek US emergency use authorization)
...
• $MillerKnoll(MLKN.US$ +12.4%, $BioNTech(BNTX.US$ +7.4%, $Lululemon Athletica(LULU.US$ +6.5% (also authorizes $1 bln stock repurchase program)
• $Adagio Therapeutics(ADGI.US$ +52.47% (announces ADG20 (adintrevimab) is the first monoclonal antibody to meet primary endpoints with statistical significance across pre- and post-exposure prophylaxis and treatment for COVID-19 and plans to seek US emergency use authorization)
...
18
8
Read more
Pinchie McPincher : theye just announced updated formluation of fostrox
Pinchie McPincher : just announced updated formulation of fostrox , criticsal to support planned study with accelrated approval intent in 2nd lineHCC